🇺🇸 FDA
Pipeline program

Valbenazine, Valbenazine, Placebo for valbenazine capsules

NBI-98854-ATS3019

Phase 3 small_molecule active

Quick answer

Valbenazine, Valbenazine, Placebo for valbenazine capsules for Schizophrenia is a Phase 3 program (small_molecule) at NEUROCRINE BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
NEUROCRINE BIOSCIENCES INC
Indication
Schizophrenia
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials